Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer

Urology

Volumn 57, Issue 3, 2001, Pages 481-485

  Batuello, Joseph T ^a   Gamito, Eduard J ^a,e   Crawford, E David ^a,b   Han, Misop ^c   Partin, Alan W ^c   McLeod, David G ^d   O'Donnell, Colin ^a  

^a Denver Colorado USA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e ANNs in CaP Project   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER MODEL; DATA BASE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; TRAINING; TUMOR BIOPSY; VALIDATION PROCESS;

FALSE NEGATIVE REACTIONS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; NEURAL NETWORKS (COMPUTER); PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0035123210     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)01039-6     Document Type: Article

References (19)

1. The changing pattern of prostate cancer at the time of diagnosis; characteristics of screen detected prostate cancer in a population based screening study
2. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice
3. Staging prostate cancer-1997; current methods and limitations
4. Prostate cancer diagnosis and management
5. PSA following anatomical radical retropubic prostatectomy; patterns of recurrence and cancer control
6. Capsular transgression of prostatic carcinoma; evaluation with transrectal US with pathologic correlation
7. Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer
8. Biological determinants of cancer progression in men with prostate cancer
9. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer
10. Combination of prostate-specific antigen, clinical stage and Gleason sum to predict pathological stage of localized prostate cancer; a multi-institutional update
11. An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level
12. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer
13. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma
14. The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer
15. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma
16. The TNM classification of prostate cancer
17. National trends in the epidemiology of prostate cancer, 1973 to 1994; evidence for effectiveness of prostate-specific antigen screening